Loading…
Beryl Drugs (BSE 524606)₹25.49−1.47%Pharmaceuticals
At the end of the Jun 2026 quarter, Beryl Drugs' shareholders were: promoters 27.86%, public 72.14%. Promoter holding is up 0.34 percentage points from 27.52% a quarter earlier. 0.00% of promoter shares were pledged. It had 7,313 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 26.42% | 26.42% | 26.42% | 26.42% | 26.42% | 26.42% | 26.42% | 26.42% | 26.42% | 26.42% | 27.52% | 27.86% |
| Public | 73.58% | 73.58% | 73.58% | 73.58% | 73.58% | 73.58% | 73.58% | 73.58% | 73.58% | 73.58% | 72.48% | 72.14% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 6,808 | 6,855 | 7,261 | 7,329 | 7,368 | 7,433 | 7,435 | 7,419 | 7,450 | 7,413 | 7,353 | 7,313 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Sanjay Sethi | Promoter | 10.87% | 0.00 |
| Sudhir Sethi | Promoter | 10.10% | +0.34 |
| Sangita Sethi | Promoter | 3.79% | 0.00 |
| Pradeep Kumar Jain | Public | 3.53% | +1.02 |
| Soniya Sethi | Promoter | 3.09% | 0.00 |
| Mayank Siyal | Public | 2.08% | 0.00 |
| Samir Narendra Gupta | Public | 1.75% | −0.14 |
| Jinesh Joseph | Public | 1.68% | 0.00 |
| Punjabhai Keshavbhai Jadeja | Public | 1.24% | 0.00 |
| Ram Babu Vijay | Public | 1.20% | 0.00 |
| Simimon Kallupurackal Joby | Public | 1.04% | 0.00 |
Promoters held 27.86% of Beryl Drugs at the end of the Jun 2026 quarter, up 1.44 percentage points from 26.42% a year earlier.
No. The Jun 2026 filing shows no pledged promoter shares.
Beryl Drugs had 7,313 shareholders at the end of the Jun 2026 quarter, against 7,419 a year earlier.
Pradeep Kumar Jain (Public) held 3.53% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.